Researchers have found a way to evaluate the cutaneous biomarkers of atopic dermatitis via a minimally invasive method using tape strips, which may offer insight into tracking pediatric treatment responses in the future, according to recent findings published in JAMA Dermatology.

“We are constantly seeking a minimally invasive means to get to the [atopic dermatitis] phenotype in children,” study author Emma Guttman-Yassky, MD, PhD, of the department of dermatology and laboratory for inflammatory skin diseases, Icahn School of Medicine at Mount Sinai Medical Center, told Healio Dermatology.